Effects of rosuvastatin on progression of stenosis in adult patients with congenital aortic stenosis (PROCAS Trial)

American Journal of Cardiology

Volumn 108, Issue 2, 2011, Pages 265-271

  Van Der Linde, Denise ^a   Yap, Sing C ^a   Van Dijk, Arie P J ^b   Budts, Werner ^c   Pieper, Petronella G ^d   Van Der Burgh, Pieter H ^e   Mulder, Barbara J M ^f   Witsenburg, Maarten ^a   Cuypers, Judith A A E ^a   Lindemans, Jan ^a   Takkenberg, Johanna J M ^a   Roos Hesselink, Jolien W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e MEDISCH SPECTRUM TWENTE   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; ROSUVASTATIN;

ADULT; AORTA; AORTA STENOSIS; AORTIC VALVE VELOCITY; ARTICLE; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE MASS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; NEOPLASM; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHABDOMYOLYSIS; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADOLESCENT; ADULT; AORTIC VALVE; AORTIC VALVE STENOSIS; BELGIUM; BLOOD FLOW VELOCITY; CALCINOSIS; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FLUOROBENZENES; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NETHERLANDS; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; PYRIMIDINES; SULFONAMIDES; YOUNG ADULT;

EID: 79959746237     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.03.032     Document Type: Article

References (19)

1. E.T. Van de Velde, J.W. Vriend, M.M. Mannens, C.S. Uiterwaal, R. Brand, B.J. Mulder CONCOR An initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: rationale, design, and first results Eur J Epidemiol 20 2005 549 557 (Pubitemid 40933933)
2. H. Baumgartner, J. Hung, J. Bermejo, J.B. Chamber, A. Evangelista, B.P. Griffin, B. Iung, C.M. Otto, P.A. Pellikka, and M. Quiones Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice J Am Soc Echocardiogr 22 2009 1 23
3. L.F. Hiratzka, G.L. Bakris, J.A. Beckman, R.M. Bersin, V.F. Carr, D.E. Casey Jr, K.A. Eagle, L.K. Hermann, E.M. Isselbacher, E.A. Kazerooni, N.T. Kouchoukos, B.W. Lytle, D.M. Milewicz, D.L. Reich, S. Sen, J.A. Shinn, L.G. Svensson, and D.M. Williams ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine Circulation 121 2010 e266 e369
4. R.B. Devereux, D.R. Alonso, E.M. Lutas, G.J. Gottlieb, E. Campo, I. Sachs, and N. Reichek Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings Am J Cardiol 57 1986 450 458 (Pubitemid 16119719)
5. E. Abergel, M. Tase, J. Bohlender, J. Menard, and G. Chatellier Which definition for echocardiographic left ventricular hypertrophy? Am J Cardiol 75 1995 498 502
6. P. Hildebrandt, and P.O. Collinson Amino-terminal pro-B-type natriuretic peptide testing to assist the diagnostic evaluation of heart failure in symptomatic primary care patients Am J Cardiol 101 2008 25 28
7. S.J. Cowell, D.E. Newby, R.J. Prescott, P. Bloomfield, J. Reid, D.B. Northridge, and N.A. Boon A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis N Engl J Med 352 2005 2389 2397 (Pubitemid 40958435)
8. W. Dichtl, H.F. Alber, G.M. Feuchtner, F. Hintringer, M. Reinthaler, T. Bartel, A. Sssenbacher, W. Grander, H. Ulmer, O. Pachinger, and S. Mller Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg) Am J Cardiol 102 2008 743 748
9. I. Hamilton-Craig, K. Kostner, D. Colquhoun, and S. Woodhouse At sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversy Heart Lung Circ 18 2009 343 346
10. K.L. Chan, K. Teo, J.G. Dumesnil, A. Ni, J. Tam ASTRONOMER Investigators Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial Circulation 121 2010 306 314
11. B.S. Brooke, J.P. Habashi, D.P. Judge, N. Patel, B. Loeys, and H.C. Dietz III Angiotensin II blockade and aortic-root dilation in Marfan's syndrome N Engl J Med 358 2008 2787 2795 (Pubitemid 351930853)
12. E. Wilton, and M. Jahangiri Post-stenotic aortic dilatation J Cardiothorac Surg 1 2006 7
13. J. Stypmann, A. Schubert, H. Welp, H. Schulte, G. Assmann, G. Breithardt, and J.R. Nofer Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure Clin Cardiol 31 2008 478 481
14. A. Bielecka-Dabrowa, J.H. Goch, D.P. Mikhailidis, J. Rysz, M. Maciejewski, and M. Banach The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy Med Sci Monit 15 2009 MS12 M23
15. M. Cemri, U. Arslan, S.A. Kocaman, and A. Cengel Relationship between N-terminal pro-B type natriuretic peptide and extensive echocardiographic parameters in mild to moderate aortic stenosis J Postgrad Med 54 2008 12 16 (Pubitemid 351311732)
16. J. Bergler-Klein, U. Klaar, M. Heger, R. Rosenhek, G. Mundigler, H. Gabriel, T. Binder, R. Pacher, G. Maurer, and H. Baumgartner Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis Circulation 109 2004 2302 2308 (Pubitemid 38678520)
17. M. Weber, M. Hausen, R. Arnold, H. Nef, H. Moellman, A. Berkowitsch, A. Elsaesser, R. Brandt, V. Mitrovic, and C. Hamm Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis Heart 92 2006 1639 1644 (Pubitemid 44629175)
18. N.M. Rajamannan Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology Am J Physiol Heart Circ Physiol 298 2010 H5 H15
19. L.M. Moura, S.F. Ramos, J.L. Zamorano, I.M. Barros, L.F. Azevedo, F. Rocha-Goncalves, and N.M. Rajamannan Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis J Am Coll Cardiol 49 2007 554 561 (Pubitemid 46177435)